Galbraith, Le Ann

Galbraith, Le Ann was paid $179K by Medicaid between Oct 2021 and Mar 2024, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.

33Billing provider infoGALBRAITH, LE ANN
DANVILLE, IL 61832

33aNPI1841770534assigned 08/21/2018

33bProvider typeNurse Practitioner

28Total paid$179K

24GClaims4,013

24DCodes billed11

24AFirst – last monthOct 2021 – Mar 2024

Compared with peers

Next to other Nurse Practitioner providers in Illinois

Rank by total paid#176 of 1,687

Median peer was paid$22K

This provider vs. median8.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	384	$15K
2022	1,557	$69K
2023	1,798	$81K
2024incomplete	274	$14K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	56%	2,280	2,151	$100K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	22%	581	542	$39K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	5.9%	229	213	$10K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	4.4%	227	205	$8K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	2.9%	172	162	$5K
87428		2.6%	74	71	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	2.3%	267	245	$4K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.9%	69	68	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	1.6%	40	40	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	13	12	$595.40
81002		<1%	61	58	$158.60

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.